For Pharma

For Oncologists

Colorectal Cancer

Pancreatic Cancer



Lung cancer                            in perspective

Cancer is a complex disease that can affect various organs and tissues in the body. At its core, cancer is a condition where cells in the body grow and divide uncontrollably, often forming tumors or spreading to other parts of the body. One of the biggest challenges in cancer treatment is the ability of cancer cells to become resistant to therapies that initially work against them. This resistance can develop through various mechanisms, including mutations that alter the cancer cell's response to treatment, the activation of survival pathways that allow cancer cells to evade treatment-induced cell death, and the presence of cancer stem cells that can give rise to new tumors even after initial treatment. Another challenge in cancer treatment is the heterogeneity of cancer, both within and between individual tumors. Cancer cells can differ in terms of their genetic and epigenetic makeup, as well as their microenvironmental context, which can influence their response to treatment. This heterogeneity can make it difficult to develop treatments that are effective for all patients with a particular type of cancer.

Brief overview on

The ABCs of NSCLC: An In-Depth Guide to Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a type of cancer that develops in the lung tissue. It is the most common type of lung cancer, accounting for about 85% of all cases. Smoking is the leading cause of NSCLC, accounting for about 85% of all cases. Other risk factors include exposure to secondhand smoke, radon gas, air pollution, and asbestos. People with a family history of lung cancer may also be at a higher risk. The prognosis for NSCLC depends on the stage of the cancer at the time of diagnosis. The 5-year survival rate for all stages of NSCLC combined is about 24%, but this can vary greatly depending on the stage and subtype of NSCLC.

Be aware

Symptoms of NSCLC

  • Coughing
  • Shortness of breath
  • Chest pain
  • Hoarseness
  • Weight loss

Diagnosis process

Detection of lung cancer

Some people may not experience any symptoms until the cancer has spread to other parts of the body. Diagnosis of NSCLC usually involves a combination of imaging tests, such as CT scans or PET scans, and tissue biopsy. The biopsy is necessary to confirm the presence of cancer cells and determine the subtype of NSCLC.



The treatment options for NSCLC depend on the stage of the cancer and the overall health of the patient. Surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy are common treatment options.Surgery is often the preferred treatment for early-stage NSCLC, while chemotherapy and radiation therapy are used for advanced stages. Targeted therapy and immunotherapy are newer treatments that may be used for specific subtypes of NSCLC.
The management of NSCLC is a complex process that necessitates a multidisciplinary approach to treatment. If you or someone you know has been diagnosed with NSCLC, it is crucial to collaborate with a team of healthcare professionals to develop a customized treatment plan.  Although the prognosis for NSCLC can be daunting, timely detection and efficient treatment can enhance the likelihood of survival.
Understanding the Complexity of Stage IV Non-Small Cell Lung Cancer Treatment: Personalized Approaches, Clinical Trials, and Molecular Features

In cases of stage IV non-small cell lung cancer (NSCLC), oncologists may utilize various chemotherapies and targeted therapies based on the patient’s individual characteristics and the molecular features of the tumor. Clinical trials or genetic testing results may influence treatment decisions. The objective of oncologists is to use the most effective and evidence-based treatments tailored to each patient’s specific situation and modify treatment plans based on the patient’s response to therapy. The difficulty of treating lung cancer depends on several factors, such as cancer type, stage, patient’s overall health, and tumor molecular characteristics. Small cell lung cancer (SCLC) is generally regarded as more aggressive and challenging to treat than NSCLC, which encompasses several subtypes. Although SCLC is typically more responsive to chemotherapy than NSCLC, it also grows and spreads faster, making it harder to cure. Nonetheless, the difficulty of treating lung cancer can vary widely based on individual patient factors. Treatment decisions should always be based on a personalized approach that considers each patient’s unique circumstances.

We’re Here Whenever You Need Us



(two six seven) 290-7779

Open Hours

Mon – Fri: 8 am – 8 pm
Sat: 10 am – 4 pm


400 Farmington Ave.,        Unit 1841, Farmington, CT